
The FDA has moved to approve Bavencio (avelumab), developed by Pfizer and EMD Serono, the biopharma arm of Merck KGaA, …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

